3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
8
Head & Neck
2
Dermatologic
2
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Ovarian Neoplasms
24
Endometrial Neoplasms
12
Uterine Cervical Neoplasms
11
Fallopian Tube Neoplasms
7
Carcinoma, Renal Cell
6
Breast Neoplasms
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Vaginal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Carcinoma, Transitional Cell
3
Uterine Neoplasms
2
Neoplasms
2
Lymphoma
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Interventions
Filgrastim
15
Carboplatin
10
Ifosfamide
9
Doxorubicin
9
Cyclophosphamide
9
Peripheral Blood Stem Cell Transplantation
7
pembrolizumab
6
Radiotherapy
6
Gemcitabine
6
Temozolomide
5
Etoposide
5
Cisplatin
5
Paclitaxel
4
Docetaxel
4
Amifostine
4
aldesleukin
3
aflibercept
3
Trastuzumab
3
Specimen Handling
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
tislelizumab
2
sodium thiosulfate
2
selinexor
2
pazopanib
2
palbociclib
2
etoposide phosphate
2
eribulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
durvalumab
×
Gynecologic
×
Clear all
NCT03085225
2025-09-04
TRAMUNE
Institut Bergonié
Phase 1
Completed
40 enrolled
23 charts